Building on this, the same group later found that anti-PD-1 therapy increased the activity of ion channels KCa3.1 and Kv1.3, leading to enhanced CD8+ T cell infiltration in head and neck squamous cell carcinoma (HNSCC) patient samples[71]. Here, PDCD1 is linked to head and neck squamous cell carcinoma.